Jobs / United States / Regeneron Pharmaceuticals INC
Associate Director, Digital Health Technologies
Regeneron Pharmaceuticals INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles13 certified filings for “Associate Director Imaging” (Natural Sciences Managers) in NY: $201k–$281k, median $225k. Most were filed at wage level II (69%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build our future together: The Associate Director – Digital Health Technology (DHT) leads the strategic management of one or more COA (Clinical Outcome Assessment) and DHT programs. This individual owns operational decisions — instrument selection, validation, debriefing, translation, DHT planning, vendor onboarding and oversight, quality, timelines, and budgets — for COA and DHT activities within assigned programs, in accordance with applicable regulations, ICH/GCP standards, and company SOPs. The role serves as a cross-functional liaison, raising awareness of Regeneron-specific COA/DHT/data integration needs, and provides oversight at both the clinical development unit/program level and the individual study level for eCOA and DHT technologies (e.g., wearables, sensors, ECG, spirometry). As the Subject Matter Expert, this person advises study teams on best practices to ensure regulatory compliance and data quality, manages vendor performance at the program level, and holds line management responsibility for staff recruitment, development, coaching, mentoring, and performance management. When & where: • Primary Location: Warren, NJ • May require up to 25% travel Discover your role: Program & Study Oversight • Accountable for the successful, compliant delivery of eCOA and DHT (wearables, sensors, ECG, spirometry) across assigned clinical programs • Executes the COA/DHT development process — study design, execution, change control, and database lock activities • Owns the overall success of COA/DHT development and strategy within assigned clinical development unit(s)/program(s) • Maintains visibility into program status and issues; proactively communicates progress, risks, and changes affecting quality, timelines, or budget • Reviews key metrics and KPIs across studies to track progress and vendor performance • Ensures inspection readiness throughout the clinical program lifecycle Planning & Setup • Leads the Program Planning and Setup phases of eCOA/DHT, including: • Guiding COA/DHT and digital endpoint selection through team collaboration and literature review • Supporting Health Economics Outcomes Research (HEOR) with instrument development • Overseeing cognitive debriefing, psychometric validation studies, and DHT verification, validation, and usability activities • Provides input during protocol development to ensure consistency across the program • Provides operational insight into COA/DHT selection, vendor options, timelines, and cost estimates during program/study development Vendor Management • May own vendor relationship management, including: • Vendor selection and maintenance • Participation in vendor governance/oversight meetings • Review, negotiation, and standardization of vendor contracts and budgets with procurement • Establishing vendor performance metrics and reviews • Delivering standard vendor/sponsor expectations and operational processes • Acting as the point of contact for trial-specific and vendor-related escalations, ensuring preventative actions are implemented • Participates in eCOA, DHT, and translation vendor governance meetings as needed Problem Solving & Risk Management • Applies problem-solving strategies and maintains issue-tracking documentation to monitor progress and ensure timely resolution • Proactively creates and implements risk mitigation strategies • Provides innovative, flexible COA/DHT solutions and scenario planning for cross-functional teams • Drives decision-making by integrating all COA/DHT operational considerations to ensure program goals are attainable before implementation • Acts as the point of contact for program- and study-level escalations Resourcing & Continuous Improvement • Responsible for COA/DHT resource forecasting and allocation acr